Preview

Filin’s Clinical endoscopy

Advanced search

Prognostic significance of mucosal transformation factors in patients with Barrett’s esophagus

https://doi.org/10.31146/2415-7813-endo-62-1-11-24

Abstract

Barrett's esophagus is an acquired pathological condition that develops as a result of the replacement of the destroyed stratified squamous epithelium of the lower part of the esophagus with a cylindrical cell epithelium, which includes goblet cells and which occurs as a result of repeated action of damaging factors on the esophageal mucosa RESEARCH OBJECTIVE, To develop an algorithm for managing patients with an established diagnosis of Barrett's esophagus before the appearance of severe dysplastic changes in the esophageal mucosa, depending on the identification of epithelial transformation factors, in order to prevent the development of the oncological process. MATERIALS AND METHODS, The work was carried out at the Moscow Medical Center for the Development of the Barrett's Disease in the period from 2013 to 2023. The study was conducted both retrospectively and prospectively. CONCLUSIONS: 1. The course of the disease and the results are different in patients belonging to the same group and having the same morphological diagnosis; 2. The presence of mild dysplasia does not affect the treatment results; the greatest success in treating patients with BP, close to the indicators in the control group, was achieved in groups ia and iia, both in total indicators for the SDTS and in the proportion of failures; 3. The lowest indicators on the GerdQ and SDTS scale and the highest proportion of failures were in group ii, which means that these patients are at risk of neoplastic transformation of the columnar epithelium; 4. Gender characteristics have a statistically significant effect on the course of the disease: in women, the treatment results are better 93% > 50 points on the SDTS compared to 84% in men (p < 0.01); 5. Age characteristics have a statistically significant effect on the course of the disease, since there is a statistically significant difference in the success rates of treatment in patients under 50 years of age (p < 0.05); 6. High results of treatment of patients by SDC> 50 points are registered in patients with absence or simultaneous growth of expression of genes p53 and p63, as well as ki-67 in the range from 20 to 40%, the obtained data are statistically reliable p<0.05; 7. The adopted algorithm of diagnostics, treatment and dynamic observation in the studied groups of patients with BP, taking into account the identified factors of neoplastic transformation of columnar epithelium, allowed to achieve high total indicators by SDC, reflecting success in achieving the set goals of treatment, 92.6% of patients had indicators> 50.

About the Authors

G. V. Belova
Federal Center for Brain and Neurotechnology” of the FMBA of Russia
Russian Federation


O. S. Utkina
Federal Center for Brain and Neurotechnology” of the FMBA of Russia
Russian Federation


References

1. Belova G. V. [Methodological aspects of diagnostics, monitoring and treatment of patients with Barrett's esophagus]. Diss...Doctor of Medical Sciences. FGU "P. A. Herzen Moscow Oncology Research Institute of the Russian Medical Technology Institute", Moscow, 2009. 240 p. (in Russ.)@@ Белова Г. В. Методологические аспекты диагностики, мониторинга и лечения пациентов с пищеводом Барретта.: Дис…докт.мед.наук // ФГУ «МНИОИ им. П. А. Герцена Росмедтехнологии» М, - 2009. 240 с.

2. Godzhello E. A., Gallinger Yu. A. [Barrett's esophagus, esophageal adenocarcinoma and tasks of modern gastroenterology]. Russian journal of gastroenterology, hepatology, proctology. 2001;(6):71-75. (in Russ.)@@ Годжелло Э.А., Галлингер Ю. А. Пищевод Барретта, аденокарцинома пищевода и задачи современной гастроэнтерологии // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. - 2001 - № 6, - С 71-75.

3. Sharma P., Hawes R.H., Bansal A. et al. Standard endoscopy with ran-dom biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: A prospective, international, randomised controlled trial. Gut. 2013 Jan;62(1):15-21. doi: 10.1136/gutjnl-2011-300962.

4. Zayratyants O. V., Maev I. V., Smolyannikova V. A. et al. Pathological anatomy of Barrett's esophagus. Archives of pathology. 2011; (3): 21-26. (in Russ.)@@ Зайратьянц О.В., Маев И. В., Смольянникова В. А. и соавторы. Патологическая анатомия пищевода Барретта. Архив патологии. 2011;(3):21-26.

5. Ivashkin V. T., Maev I. V., Trukhmanov A. S. et al. [Barrett's esophagus. Clinical guidelines]. Moscow. 2014. (in Russ.)@@ Ивашкин В. Т., Маев И. В., Трухманов А, С и др. «Пищевод Барретта» Клинические рекомендации. 2014, Москва.

6. Efremov L. I., Komissarenko I. A. Metabolic continuum and polymorbidity in geriatrics. Experimental and clinical gastroenterology. 2014;(6):4-7. (in Russ.)@@ Ефремов Л.И., Комиссаренко И. А. Метаболический континум и полиморбидность в гериатрии. Экспериментальная и клиническая гастроэнтерология. -2014 г. -№ 6. - С 4-7.

7. Metabolic syndrome. Ed. G. E. Roytberg. Moscow. Medpress-inform, 2007; 223 p. (in Russ.)@@ Метаболический синдром. Под ред. Г. Е. Ройтберга /М.: Медпресс-информ, 2007;223 с.

8. Metabolic syndrome. Edited by V. Fonseca. Translated from English. Moscow. “Praktika”, 2011. 272 p. (in Russ.)@@ Метаболический синдром. Под ред. В. Фонсеки. Пер.с англ. - М.: «Практика», 2011. -272 с. 9.

9. Hoyo C., Сook M.B., Kamangar F. et al.Boody mass index in relation to oesophageaj and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACONсonsortium. Int J Epidemiol. 2012 Dec;41(6):1706-18. doi: 10.1093/ije/dys176.

10. Singh S., Sharma A. N., Murad M. H., et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1399-1412.e7. doi: 10.1016/j.cgh.2013.05.009.


Review

For citations:


Belova G.V., Utkina O.S. Prognostic significance of mucosal transformation factors in patients with Barrett’s esophagus. Filin’s Clinical endoscopy. 2023;62(1):11-24. (In Russ.) https://doi.org/10.31146/2415-7813-endo-62-1-11-24

Views: 49


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2415-7813 (Print)